Global Oral Proteins and Peptides Market to Reach US$ 3.3 Billion by 2032, Accelerated by Increasing Prevalence of Chronic Diseases

July 12, 2023 | Healthcare

As per the latest report by IMARC Group, titled "Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2024-2032," the global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Oral proteins and peptides are substances that are administered orally, typically in the form of capsules, tablets, or liquid formulations. They have emerged as a breakthrough in the field of drug delivery, offering an alternative to traditional injection-based methods. Their manufacturing involves meticulous formulation techniques to ensure stability and bioavailability. The efficacy of oral proteins and peptides lies in their ability to mimic natural physiological processes. Once administered, these macromolecules interact with specific receptors in the gastrointestinal tract, triggering cellular signaling pathways. This interaction facilitates the transport of the therapeutic molecules across the epithelial barrier and into the systemic circulation, where they can reach their target tissues or organs. By leveraging the body's natural absorption mechanisms, oral delivery offers a convenient and non-invasive route for administering these biologics. The advantages of oral protein and peptide delivery include eliminating the need for injections, thus providing a more patient-friendly experience. This non-invasive approach improves compliance, especially for long-term treatments. Furthermore, oral administration enables self-administration, reducing the burden on healthcare systems. It also offers the potential for improved drug stability and reduced manufacturing costs compared to injectable formulations.

Global Oral Proteins and Peptides Market Trends:

The global oral proteins and peptides market is influenced by several key factors, including the increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, and advancements in drug delivery technologies and formulations. Furthermore, the growing geriatric population, coupled with the rising awareness about preventive healthcare, has increased the demand for oral protein and peptide-based supplements, thus driving the market growth. Moreover, the extensive research and development (R&D) activities in the biotechnology and pharmaceuticals sectors, focusing on the development of innovative oral protein and peptide therapeutics, are fueling the market growth. Additionally, increasing investments by key market players in the development and commercialization of oral protein and peptide drugs are bolstering the market growth. Besides this, the rising healthcare expenditure and the favorable government initiatives to promote the use of oral protein and peptide therapeutics are contributing to the market growth. Additionally, the growing preference for non-invasive drug delivery methods and the surging awareness about the advantages offered by oral proteins and peptides, such as reduced side effects and improved patient compliance, are strengthening the market growth. Looking forward, the market value is projected to reach US$ 3.3 Billion by 2032, expanding at a CAGR of 7.51% during 2024-2032.

Market Summary: 

  • By the drug type, the market has been segmented into linaclotide, plecanatide, calcitonin, insulin, and octreotide. At present, insulin dominates the market.
  • Based on the application, the market has been classified into gastric and digestive disorders, bone diseases, diabetes, and hormonal disorders. Currently, diabetes account for the largest market share.
  • On the basis of the region, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. At present, North America dominates the market.
  • The competitive landscape of the industry has also been examined with some of the key players being Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Drug Types Covered Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide
Applications Covered Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders
Regions Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amryt Pharma Plc, AstraZeneca PLC, Biocon Limited, Novo Nordisk A/S, Oramed Ltd, Proxima Concepts Limited, etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Oral Proteins and Peptides Market to Reach US$ 3.3 Billion by 2032, Accelerated by Increasing Prevalence of Chronic Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More